medline.ch Onkologie Blut

	Acquired Hemophilia A Revealing Occult Splenic Marginal Zone Lymphoma. Am J Case Rep Brahmanapalle HS, Arora A. PMID: 42467605 [PubMed - indexed for MEDLINE]
	Acalabrutinib in patients with mantle cell lymphoma subjected to allogeneic hematopoietic cell transplantation. a phase 2 study by the Polish Lymphoma Research Group (PLRG12 trial). Ann Hematol Giebel S, Czy, Hus I, Gil L, Giannopoulos K, Romejko-Jarosi, Majcherek M, Szeremet A, Wache A, Kwa, Swoboda R, Jurczak W. PMID: 42467258 [PubMed - as supplied by publisher]
	CD5+ CD10+ lymphoplasmacytic lymphoma with cutaneous histologic transformation in a post-transplant setting. J Hematop Mulvena MT Jr, Sadigh S, Jacobsen ED, Wu SJ. PMID: 42467117 [PubMed - indexed for MEDLINE]
	Aggressive B-cell Lymphoma Masquerading as Benign Epstein-Barr Virus (EBV)-Related Splenomegaly: An Analysis of Diagnostic Anchoring Bias. Cureus Savadkar A, Chauhan I, Sharma M, Rallabandi S, Patil P, Benaka Hebbar V, Kashyap R. PMID: 42465140 [PubMed]
	Monocytose rÃ©actionnelle versus clonale : la leucÃ©mie myÃ©lomonocytaire chronique. Rev Med Suisse Nabergoj M, Bou Mjahed R, Basset V, Tsilimidos G, Blum S. PMID: 42464748 [PubMed - indexed for MEDLINE]
	Prognostic impact of presentation phenotypes in early-stage favorable Hodgkin lymphoma. Cancer Tharmaseelan H, Jablonski J, Bühnen I, Fuchs M, Rosenbrock J, Eich HT, Ferdinandus J, Jaworek CP, Bröckelmann PJ, Borchmann P, Eichenauer DA. PMID: 42464601 [PubMed - indexed for MEDLINE]
	Coronavirus disease 2019 (COVID-19) risk and evolving treatment patterns in follicular lymphoma during the pandemic: Insights from the PETReA trial. Br J Haematol Williams S, Lim YJ, Cooper R, Gamble C, Short H, Arumainathan A, Eyre TA, McKay P, Young M, Bishton M, Gatto S, Macheta M, Zhelyazkova A, Heartin E, Miall F, Warbey V, Opat S, Johnston A, Trotman J, Linton K, Pettitt A. PMID: 42463998 [PubMed - as supplied by publisher]
	Asciminib monotherapy in patients with BCR::ABL1 T315I-mutated chronic-phase chronic myeloid leukemia: phase 1 trial final results. Leukemia Cortes JE, Rea D, Mauro MJ, Hochhaus A, Kim DW, Sasaki K, Lang F, Heinrich MC, Breccia M, Deininger M, Goh YT, Janssen JJWM, Talpaz M, Gómez García de Soria V, le Coutre P, Mahon FX, DeAngelo DJ, Damon A, Kapoor S, Sanchez-Olle G, Hoch M, Agrawal N, Quenet S, Hughes TP. PMID: 42463944 [PubMed - as supplied by publisher]
	Dose-reduced (24 Gy) involved-site radiotherapy combined with rituximab in early-stage non-gastric mucosa-associated lymphoid tissue lymphoma: a prospective phase II trial. Leukemia Liu H, Cheng Y, Liu S, Zhang X, Ma J, Lu J, Wang C, Sun M, Zhao X, Cao L, Qu X, Wang S, Shen H, Tian T, Zhao Y, Ding C, Sheng L, Ding K, Fan L. PMID: 42463943 [PubMed - as supplied by publisher]
	Englumafusp alfa plus glofitamab in Bâ€‰cell non-Hodgkin lymphoma: a phase 1 trial. Nat Med Hutchings M, Dickinson M, Gritti G, Carlo-Stella C, Townsend W, Bosch F, Bartlett NL, Cartron G, Ghesquieres H, Houot R, Walter H, Offner F, Dimier N, Jamois C, Herter S, Keelara A, Wilson S, Gallien J, Hinton H, Gonzalez-Albo IP, Korfi K, Kazantzidis G, Wasmer MH, Lechner K, Morschhauser F. PMID: 42463852 [PubMed - as supplied by publisher]
	Favorable outcomes after early allogeneic stem cell transplantation in adult early T-cell precursor acute lymphoblastic leukemia treated with the pediatric-inspired GIMEMA LAL1913 program. A Campus ALL study. Bone Marrow Transplant Cavallaro G, Lazzarotto D, Pavoni C, Valsecchi F, Grassi A, Cerrano M, Defina M, Lunghi M, Giglio F, Imbergamo S, Lanzarone G, Mulè A, Salutari P, Zappasodi P, Bonifacio M, Chiusolo P, Delia M, Mauro E, Mazzone C, Skert C, Rambaldi A, Chiaretti S, Foà R, Candoni A, Lussana F. PMID: 42463829 [PubMed - as supplied by publisher]
	Safety and efficacy of immune checkpoint inhibitors as a bridge to allogeneic hematopoietic stem cell transplantation in classical Hodgkin lymphoma: A systematic review and meta-analysis. Transpl Immunol Jain P, Thompson J, Panchal V, Shah V, Ganatra N, Patel S, Patel A, Anwar J. PMID: 42462932 [PubMed - as supplied by publisher]
	From the archives of MD Anderson Cancer Center: Crystal-storing histiocytosis associated with B-cell lymphoma. Ann Diagn Pathol Al-Rusan O, Shen Q, Medeiros LJ. PMID: 42462588 [PubMed - as supplied by publisher]
	Nursing Considerations for CAR T-Cell Therapy: Management of Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome. Clin J Oncol Nurs Miller DM. PMID: 42462106 [PubMed - indexed for MEDLINE]
	The impact of radiotherapy on the therapeutic response of patients treated with CAR T-cell therapy for high-grade lymphoma: a systematic review. Leuk Lymphoma Belghoul M, Kuhnl A, Chevassut T, Sanderson R, Mikhaeel G, Benjamin R, Patton P, Jones J. PMID: 42461700 [PubMed - as supplied by publisher]
	Healthcare resource utilization analysis in newly diagnosed mantle cell lymphoma: resource alleviation with adoption of the TRIANGLE ibrutinib regimen without autologous stem cell transplantation. Ann Hematol Wißkirchen J, Rogmann NS, Greiling M, Ries F, Ohler A, Hess G, Osygus J. PMID: 42461392 [PubMed - indexed for MEDLINE]
	Large Granular Lymphocytes and Large Granular Lymphocytic Leukemia: A Real-World Case-Control Study. Turk J Haematol Liu C, Liu Y, Li Y, Chen S, Cai W, Zheng Y, Dong Y, Lu X, Xiao J, Sun Q. PMID: 42460737 [PubMed - as supplied by publisher]
	BCR-ABL1 Transcript Variants in Chronic Myeloid Leukemia Patients in Africa: A Systematic Review. Health Sci Rep Emeline Oloume M, Pieme A, Ngalle CK, Tapouli R, Tagny CT. PMID: 42460242 [PubMed]
	Classical Hodgkin Lymphoma Today. Mediterr J Hematol Infect Dis D'Alò F, Schiaffini G, Mazzoni D, Alma E, Bellisario F, Viscovo M, Maiolo E, Bellesi S, Hohaus S. PMID: 42460098 [PubMed]
	Jiedu Xiaoliu formula enhances progression-free survival and immune modulation in diffuse large B-cell lymphoma: a retrospective cohort study. Front Pharmacol Yirong C, Hongyu Z, Wenwen J, Qi H, Jiahui L. PMID: 42460022 [PubMed]

Artikel 1 - 20 / 169137

Seite 1 von 8457

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung